Superficial hyperthermia combined with hypofractionated radiotherapy of malignant melanoma metastases to skin and lymph nodes

被引:0
作者
Miszczyk, Leszek [1 ]
Owczarek, Grzegorz [1 ]
Juda, Cezary [2 ]
机构
[1] Instytut Oddzial Gliwicach, Centrum Onkol im M Sklodowskiej Curie, Zaklad Radioterapii, Wroclaw, Poland
[2] Dolnoslaskie Centrum Transplantacji Komsrkowych K, Oddzial Onkol, Wroclaw, Poland
来源
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2006年 / 10卷 / 05期
关键词
superficial hyperthermia; malignant melanoma; hypofractionation; palliative treatment; radiohyperthermia; melanoma metastases;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The evaluation of combined radiohyperthermia in the treatment of skin and lymph nodes malignant melanoma metastases. Material and method: Material comprises 10 skin and 11 lymph nodes melanoma metastases (13 patients) treated with combined superficial hyperthermia and irradiation. The tumor diameter before the treatment varied from 0.5 to 7 cm (mean 2.9). All patients were treated using three 1 hour hyperthermia sessions and three 9 Gy radiation doses delivered within 8 days. The follow up period varied from 1 to 18 months (mean 4.6). Patients were examined on the day of treatment completion, 2 and 6 weeks later and next every three months. The skin reaction and tumor regression were evaluated. Impact of different biological factors for skin reaction and treatment result were checked. Results: The most frequent skin reaction was erythrema (51% of cases on the day of treatment end) and blisters (19% of cases 6 weeks after the treatment). Means of tumor diameter 0.5, 1.5, and 4.5 months after the treatment were 2.3, 2.3 and 2.4 cm, respectively. The biggest percentage of complete regressions was observed 1.5 and 4.5 months after the treatment, 33.5% and 43%, respectively. Significant dependencies between skin reaction 2 weeks after the treatment and red blood cells count in this time and before the treatment were found. Conclusion: The combined radiohyperthermia is safe and effective treatment modality of superficial melanoma metastases and could be an alternative for palliative surgery.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 31 条
[1]  
Alexander HR, 2003, CLIN CANCER RES, V9, P6343
[2]   Predictors of outcome after hyperthermic isolated limb perfusion - Role of tumor response [J].
Aloia, TA ;
Grubbs, E ;
Onaitis, M ;
Mosca, PJ ;
Cheng, TY ;
Seigler, H ;
Tyler, DS .
ARCHIVES OF SURGERY, 2005, 140 (11) :1115-1120
[3]   CHEMOIMMUNOTHERAPY OF ADVANCED MALIGNANT-MELANOMA - SEQUENTIAL ADMINISTRATION OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA AFTER INTRAVENOUS DACARBAZINE AND CARBOPLATIN OR INTRAVENOUS DACARBAZINE, CISPLATIN, CARMUSTINE AND TAMOXIFEN [J].
ATZPODIEN, J ;
HANNINEN, EL ;
KIRCHNER, H ;
FRANZKE, A ;
KORFER, A ;
VOLKENANDT, M ;
DUENSING, S ;
SCHOMBURG, A ;
CHAITCHIK, S ;
POLIWODA, H .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) :876-881
[4]   Low-dose integrated chemoimmunohormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma - A pilot study [J].
Bernengo, MG ;
Doveil, GC ;
Bertero, M ;
Quaglino, P ;
Fierro, MT ;
Savoia, P ;
Appino, A ;
Colonna, S .
MELANOMA RESEARCH, 1996, 6 (03) :257-265
[5]   Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-α in patients with metastatic melanoma [J].
Cao, MG ;
Malvehy, J ;
Martí, R ;
Conill, C ;
Sánchez, M ;
Martín, M ;
Carrera, C ;
Herrero, J ;
Gascón, P ;
Mellado, B ;
Castel, T ;
Puig, S .
MELANOMA RESEARCH, 2006, 16 (01) :59-64
[6]   Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies [J].
Ciechomska, I ;
Legat, M ;
Golab, J ;
Wesolowska, A ;
Kurzaj, Z ;
Mackiewicz, A ;
Kaminska, B .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (01) :59-67
[7]   THERMORADIOTHERAPY OF MALIGNANT-MELANOMA [J].
EMAMI, B ;
PEREZ, CA ;
KONEFAL, J ;
PILEPICH, MV ;
LEYBOVICH, L ;
STRAUBE, W ;
VONGERICHTEN, D ;
HEDERMAN, MA .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1988, 4 (04) :373-381
[8]  
ENGIN K, 1995, CLIN CANCER RES, V1, P139
[9]   HYPERTHERMIA AND RADIATION IN ADVANCED MALIGNANT-MELANOMA [J].
ENGIN, K ;
TUPCHONG, L ;
WATERMAN, FM ;
MOYLAN, DJ ;
NERLINGER, RE ;
LEEPER, DB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 25 (01) :87-94
[10]  
Izycki D, 2004, WSPOLCZESNA ONKOL, V8, P124